---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017865"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T20:56:21.496493+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Inogen Q1 2023 revenue $72.2M, net loss $20.3M; sees positive adjusted EBITDA by Q4 2023

## Summary
- Total revenue $72.2M, down 10.2% YoY; rental revenue up 25.4% YoY.
- GAAP net loss $20.3M vs $14.2M loss in Q1 2022; adjusted net loss $14.5M vs $8.7M.
- Adjusted EBITDA loss $11.8M vs $5.0M loss; expects positive adjusted EBITDA by Q4 2023.
- Cash and marketable securities $174.6M; no debt outstanding.
- Notified of France reimbursement for Rove 6; added two large private payers covering ~160M lives.

## SEC filing metadata
- accession: 0000950170-23-017865
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/0000950170-23-017865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/ingn-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017865
- JSON: https://secwatch.observer/filing/0000950170-23-017865.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017865.txt

## Key facts
- Earnings Releases
  Inogen Inc reported the quarter ended March 31, 2023 results: revenue $72.2 million, net income GAAP net loss of $20.3 million.
  - Period: the quarter ended March 31, 2023
  - Revenue: $72.2 million
  - Net income: GAAP net loss of $20.3 million
  - Result: reported results
  source text: Inogen Announces First Quarter 2023 Financial Results Total Revenue of $72.2 Million In Line with Company Expectations Rental Revenue Year-over-Year Growth of 25% GOLETA, Calif., May 04, 2023 -- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/0000950170-23-017865-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.